The following primary antibodies were used: anti-MC5-R (Alomone Labs, Jerusalem, Israel, # AMR-025), anti--MSH (Bioss, MA, USA, # BS-1848R), anti-phospho-JNK (Cell Signaling Tech, # 4668), anti-JNK (R&D Systems, # AF-1387), anti-phospho-ERK1/2 (Cell Signaling Tech, # 9107), anti-ERK1/2 (Cell Signaling Tech, # 9106), anti-phospho-p38 (Cell Signaling Tech, # 9215), anti-p38 (Cell Signaling Tech, # 9212), anti-phospho-AMPK (Cell Signaling Tech, # 2535), anti-AMPK (Cell Signaling Tech, # 2532), anti-phospho-Akt (R&D Systems, # AF887), anti-Akt (R&D Systems, # MAB2055), anti-phospho-CREB (ThermoFisher, # MA5-11192), anti-CREB (Cell Signaling Tech, #9197) and anti-NT-proBNP (Abcam, # ab13115) antibody
Recently, new therapies like Keytruda have radically changed the treatment of cancer, while more established therapies, like GLP-1s and SGLT2 inhibitors, have suddenly changed the treatment of diabetes and heart failure, respectively
Kidney Function Protection Studies have shown that GLP1 can help reduce markers of kidney disease progression in diabetic patients
Ozempic is purely a diabetes management medication, whereas Wegovy is crafted for weight loss
I left the hospital system to open this practice because I wanted to be that doctor
